London surgeons have pioneered a “game-changing” infrared imaging technique that could aid the treatment of cancer in children.The technique, called “molecular imaging”, involves the injection of chemicals into the bloodstream which act as imaging probes. These are attracted to cancerous cells in the body and, once attached, light up through a process called “fluorescence”. This in turn lights up the tumour.Dr Stefano Giuliani, Consultant Paediatric Surgeon at Great Ormond Street Hospital, said, 'This technique effectively lights up the tumour, allowing surgeons to remove it with unprecedented precision'.  The technique will benefit children with cancerous tumours.More information:  https://au.news.yahoo.com/london-scientists-pioneer-game-changing-1250

"Every year miscarriage affects up to 150,000 Australians and the people that love them. So why are we so damned bad at dealing with it?" asks Isabelle Oderberg, seasoned journalist and author of Hard to Bear: Investigating the science and silence of miscarriage. Combining in-depth investigation with lived experience, Hard to Bear charts a course to improve the system and change the lives of anyone directly or indirectly touched by early pregnancy loss, with practical and generous advice and suggestions along the way. I've bought my copy, and I encourage you to get yours: https://www.hardtobear.com

In a world-first, Australian researchers examined data from 17 global studies that included more than a million patients. Sci

A world-first surgical technique performed by an Australian surgeon using a groundbreaking Australian-Singaporean 3D implant has p

New AI-powered smart glasses give deaf or hard-of-hearing people live captions of their conversations.The new glasses use a technology called XRAI Glass which converts audio into text in real-time. The glasses work via a smartphone app and also let the wearer rewind conversations.  https://www.cbsnews.com/miami/news/captioned-smart-glasses-let-deaf-people-see-rewind-conversations/

A new class of SARS-CoV-2 antibodies has been shown to neutralise multiple variants of the virus, providing hope for a better antiviral medication to prevent according to a new study from the Garvan Institute of Medical Research.  “Almost all commercially available antibodies for COVID-19 don’t work well anymore, says Dr Jake Henry, Research Officer at the Garvan Institute.  The research shows that the class 6 antibodies effectively neutralise SARS-CoV-2 variants, including Delta and Omicron strains.  Prof. Daniel Christ says, 'This is a new mechanism of action we’re seeing with these class 6 antibodies.'See article at: https://www.garvan.org.au/news-events/news/a-new-tool-in-the-arsenal-agains